Charles S. Hesdorffer, MD [clinicaltrials_resource:5afedd2b8259dde9d9e5992c421d0c41]
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer [clinicaltrials:NCT00007982]Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis [clinicaltrials:NCT00007995]Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma [clinicaltrials:NCT00008008]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia [clinicaltrials:NCT00008190]Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer [clinicaltrials:NCT00008203]
overall official [clinicaltrials_vocabulary:overall-official]
Charles S. Hesdorffer, MD [clinicaltrials_resource:5afedd2b8259dde9d9e5992c421d0c41]
Bio2RDF identifier
5afedd2b8259dde9d9e5992c421d0c41
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5afedd2b8259dde9d9e5992c421d0c41
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Charles S. Hesdorffer, MD
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:5afedd2b8259dde9d9e5992c421d0c41
title
Charles S. Hesdorffer, MD
@en
type
label
Charles S. Hesdorffer, MD [clinicaltrials_resource:5afedd2b8259dde9d9e5992c421d0c41]
@en